Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

Whistleblower Lawyers Call for DOJ Coronavirus Fraud Task Force

By David W.S. Lieberman on March 19, 2020
Email this postTweet this postLike this postShare this post on LinkedIn
CDC-coronavirus-image-23311-for-web.jpg

Whistleblower lawyers have requested that the Department of Justice establish a task force to fight coronavirus related health care fraud according to Bloomberg Law.  One of the unfortunate but predictable responses to a national crisis is that criminals will try to take advantage.  This was true of Hurricane Katrina, the financial crisis, and will likely be true here as well.

The government has responded to crises like this before by establishing specialized task forces to attack specialized fraud.  Most recently, the government established a nursing home fraud task force.  We think a such an approach makes sense here.

Watch Out for Coronavirus Testing Fraud

Our partner Bob Thomas has recently sounded the alarm for genetic testing fraud.  Groups of criminals call seniors. The then invite them to take “free” tests to screen them and their family for propensity for cancer.  The criminals then bill the government for these tests and lie about the patient’s condition to justify payment.

With coronavirus, we’d expect to see something similar.  Now that Congress has allocated funds to ensure tests without copayment, we expect aggressive fraudsters will use similar networks to push “free” testing on populations who are not priorities for the important test, and may not have any medical need for it at all.  Genetic testing fraud merely drains federal funds that could better be used to help the sick.  Coronavirus testing fraud runs the risk of misallocating scarce testing resources away from the areas they are most needed.

Watch Out for Coronavirus Pharmaceutical Fraud

We’ve repeatedly discussed the scourge of compounding pharmacies that craft “custom” compounds designed primarily based on their high reimbursement rates rather than patient needs.  We would expect to see similar schemes that peddle expensive compounds of questionable effectiveness.  Similarly, while it is important that the government and doctors be able to use drugs in novel ways to treat new diseases like coronavirus, beware of sales people using the crisis to make unfounded claims about their products.

Watch Out for Coronavirus Price Gouging

We have handled a number of cases involving vendors seeking to dramatically raise the prices of their products to extract large sums from the government.  Most recently the government intervened in our case against Mallinckrodt for doing just this while raising the price of its drug from under $1 to over $40,000 per dose.  Be careful of vendors who seek to take advantage of this crisis by dramatically raising their prices for drugs and supplies including masks, gowns, gloves, etc.

Conclusion

In this time of crisis, it is important that we all pull together.  Part of that includes working to make sure that criminals do not use the crisis as an opportunity to profit from the fear and uncertainty.  We will continue to look out for and fight fraud related to this crisis.

David W.S. Lieberman

David W. S. Lieberman, an experienced complex commercial litigator and former Assistant Attorney General, focuses his practice on representing whistleblowers prosecuting fraud under the False Claims Act and other qui tam statutes as a Member of the Whistleblower Law Collaborative. He writes…

David W. S. Lieberman, an experienced complex commercial litigator and former Assistant Attorney General, focuses his practice on representing whistleblowers prosecuting fraud under the False Claims Act and other qui tam statutes as a Member of the Whistleblower Law Collaborative. He writes about issues involving the False Claims Act and other qui tam and whistleblower statutes.

Email
Show more Show less
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Whistleblower Law Collaborative Blog and News
  • Organization:
    Whistleblower Law Collaborative, LLC
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo